VEGFA and retinopathy of prematurity: In the selected cases presented by us using monotherapy, lesion regression was achieved at a dose of 0.12 mg, which may indicate that proper diagnosis and classification of ROP and immediate initiation of anti-VEGF therapy may prove to be effective, without the additional inclusion of laser coagulation, usually in neonates with fewer systemic burdens.